Click here to download the full detailed program. (1.33 MB PDF)

AHIA National Conference 2005

The Pathway to Sustainable Affordability

8-10 November 2005

The AHIA 2005 Conference considered the future of Health Insurance in Australia and the increasing challenges faced by health funds to provide an affordable and quality product to the consumer. Issues that were addressed included:

  • strategies for change for addressing an ageing population
  • chronic diseases
  • growing membership
  • the impact of medical technology and innovation on costs

Conference Presentations

Click on each of the speaker’s name below to download their presentations in PDF version. Presentation downloads are available for all invited speakers that have approved their work for web publication.

Speakers and Presentations
Sustainable affordability in health care financing
& delivery
Bernard J Tyson, Senior Vice President, Brand Strategy and Management, Kaiser Foundation Health Plan, Inc. and Kaiser Foundation Hospitals


  • Sustainable affordability in health care financing and delivery from the perspective of Kaiser Permanente
  • The challenges to sustainable health care financing and delivery
  • Achievement and current challenges of Kaiser Permanente
  • Private sector solutions to affordable health care delivery
  • Improving the efficiency and quality of health care
  • Developing patient-centred care
  • Implications for private health insurance in Australia
Sustainable affordability – Australian and New
Zealand experiences with Private Health Insurance
Professor Ian Harper, Executive Director, Melbourne Business School


  • The Benefits of Private Health Insurance
  • Effect of the rebate on public hospital waiting lists
  • Private health insurance and sustainable affordability in Australia
Dr Ian McPherson, Chief Executive Officer, Southern Cross Healthcare, New Zealand


  • Update on the role of private health insurance in New Zealand
  • The challenge of sustainability for Southern Cross Health Fund
  • Private health insurance innovations
  • Medical savings accounts
  • Implications for private health insurance in Australia
Chronically ill patients – Health fund approaches
to coordination of care and self management
Bruce Levy, Group Manager, Health Services, Medibank Private
Chronic Care Initiatives at Medibank Private

  • Medibank Private’s approach to chronic care
Virginia Haggar, Director-Education, International
Diabetes Institute
  • A provider perspective
  • The results of Medibank-on-Track Program – diabetes management pilot
Keith Finney, General Manager, Provider & Procurement, BUPA Australia Health
  • BUPA’s approach to chronic care
  • A clinician’s perspective
  • Patient perspective: how AuseMed has helped
Responses to providing
better quality health care at an affordable cost; The
potential for more effective use of data
DR Martin Van Der Weyden, Editor, The Medical Journal of Australia Safety in Australian Healthcare: who cares?

  • The safety of Australian Health Care – QAHCS Study, sentinel events, incidents and scandals
  • The need for reform
  • Clinical workforce shortages and health care financing challenges
  • Role of Australian Council for Quality & Safety in Health Care
  • Urgent areas for action
  • Implications for private health insurance
The Hon DR Michael Wooldridge
  • The mixed public/private Australian health system
  • Overview of Australian health and health service indicators and international comparative data
  • Using data to improve health services
  • Barriers to linking data and establishing effective databases in Australia
Professor Peter Collignon, Director, Infectious Diseases Unit, The Canberra Hospital (Presentation
delivered by Professor Lindsay Grayson, Infectious Diseases Department, Austin Health and Department of Medicine, University of Melbourne)

(10.2 MB ppt)
  • The extent of health care associated infections in Australian hospitals
  • Staphylococcus aureus and MRSA
  • Trends and outlook
  • Clinical presentation of patients
  • High risk patients
  • National strategies for prevention
  • Data collection and monitoring
  • Impact on health care quality, patient outcomes and costs
An ageing Australia: Implications
for health expenditure and private health insurance
Bernard Salt, Partner, KPMG

(2.2 MB ppt)

  • Demographic trends and an ageing Australia
  • Current outlook
  • Health expenditure and health insurance implications
Rhonda Parker, Chief Executive, Positive Ageing Foundation of Australia

(261 KB ppt)

  • Research findings on the impact of ageing
  • Trends
  • Healthy ageing
  • Needs of mature people
  • Services and programs to promote successful ageing
  • Implications for health insurers


Professor Allan McLean, Director, National Ageing Research Institute

(2.6 MB ppt)

  • The biology of ageing
  • Cause, prevention and cure of disease
  • Consequences of ageing and its social accompaniments
  • Lessons for health insurers
Musculoskeletal disease
and injury, treatment and rehabilitation
Professor Stephen Graves, Director, Australian Orthopaedic Assoc. National Joint Replacement Registry

(926 KB ppt)

The Scope of Musculoskeletal Disease – Treatment and Costs

  • The scope of musculoskeletal disease
  • Incidence, prevalence, extent of the disease
  • Trends and implications for treatment and coverage
  • Cost implications
  • Patient management
  • Joint replacement
  • Improving health outcomes and reducing cost.
DR Marlene Fransen, Senior Research Fellow, Injury Prevention and Trauma Care, The George Institute for International Health, University of Sydney

(12 MB ppt)

  • Extent of knee replacement operations in Australia
  • Trends
  • Demographics
  • Post-operative recovery and rehabilitation outcomes
  • Cost-effectiveness and scientific evidence
  • Implications for private health insurance


Can we keep pharmaceutical costs affordable
and new medicines viable?
Professor Andrew Wilson, Chair, Economic Committee, Pharmaceutical Benefits Advisory Committee, DoHA

(148 KB ppt)

  • Overview of the Pharmaceutical Benefits Scheme
  • Special Access and High Cost Drugs
  • Current coverage and expenditure
  • Future trends
  • Impact of new technologies and high cost drugs
  • Drugs in the pipeline
  • Role of PBAC
  • Evaluation methods used in PBAC decision-making
  • Implications for private health insurance
The ACCC view of key competition issues
impacting on the Private Health Sector
John Martin, Commissioner, Australian Competition and Consumer Commission

(326 KB ppt)

  • The ACCC approach to approval of recent large merger proposals, such as Ramsay/Affinity
  • Update on ACCC’s monitoring of anti-competitive practices impacting on private health insurance
  • ACCC view of sustainable affordability and whether hospital mergers and takeovers result in lower prices for consumers
  • Competition, health funds and the privatisation of Medibank Private
  • Future outlook for the private health sector from the ACCC viewpoint
You must be logged in to post a comment.